TIGIT and neoplasm: At the cellular level, scRNA-seq and CyTOF of NSCLC patients revealed that while PD-1 and TIGIT were expressed throughout the CD8+ T cell compartment, CD226 and CD28 were co-expressed by distinct populations likely important for tumor immunity.